[email protected] +44 20 8123 2220 (UK) +1 732 587 5005 (US) Contact Us | FAQ |

India Diabetes Market Report 2017

November 2017 | 126 pages | ID: IA77E64AB20EN
BisReport Information Consulting CO., Ltd

US$ 2,350.00

E-mail Delivery (PDF)

Download PDF Leaflet

Wire Transfer
Checkout Later
Need Help? Ask a Question
With the slowdown in world economic growth, the Diabetes industry has also suffered a certain impact, but still maintained a relatively optimistic growth, the past four years, Diabetes market size to maintain the average annual growth rate of 1.96% from 401 million $ in 2013 to 425 million $ in 2016, BisReport analysts believe that in the next few years, Diabetes market size will be further expanded, we expect that by 2021, The market size of the Diabetes will reach 456 million $.

This Report covers the manufacturers’ data, including: shipment, price, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the competitors better.

Besides, the report also covers segment data, including: type segment, industry segment, channel segment etc. cover different segment market size, both volume and value. Also cover different industries clients information, which is very important for the manufacturers. If you need more information, please contact BisReport

Section 1: Free - Definition

Section (2 3): 1200 USD - Manufacturer Detail

GSK
Eli Lilly
Sumitomo Dainippon Pharma
Intarcia Therapeutics
Servier
Jiangsu Hansoh Pharmaceutical
Novo Nordisk
Emisphere
Uni-Bio Science Group
Takeda
3SBio
Merck
Dong-A Pharmaceutical
Luye Pharma Group
Eurofarma
Geropharm
Alkem Labs
SatRx
Pfizer
Jiangsu Hengrui Medicine

Section (4 5 6): 1200 USD

Product Type Segmentation (Alpha-glucosidase Inhibitors, Amylin Agonists, Biguanides, Dipeptidyl Peptidase-4 (DPP4) Inhibitors, Glinides / Meglitinides)
Industry Segmentation (Hospital Pharmacy, Retail Pharmacies, Online Pharmacy)
Channel (Direct Sales, Distributor) Segmentation

Section 7: 400 USD - Trend (2017-2021)

Section 8: 300 USD - Product Type Detail

Section 9: 700 USD - Downstream Consumer

Section 10: 200 USD - Cost Structure

Section 11: 500 USD
Conclusion
SECTION 1 DIABETES PRODUCT DEFINITION

SECTION 2 INDIA DIABETES MARKET MANUFACTURER SHARE AND MARKET OVERVIEW

2.1 India Manufacturer Diabetes Shipments
2.2 India Manufacturer Diabetes Business Revenue
2.3 India Diabetes Market Overview

SECTION 3 MANUFACTURERS WHO HAVE DIABETES BUSINESS IN INDIA INTRODUCTION

3.1 GSK Diabetes Business Introduction
  3.1.1 GSK Diabetes Shipments, Price, Revenue and Gross profit 2013-2016
  3.1.2 GSK Diabetes Business Distribution by Region
  3.1.3 GSK Interview Record
  3.1.4 GSK Diabetes Business Profile
  3.1.5 GSK Diabetes Product Specification
3.2 Eli Lilly Diabetes Business Introduction
  3.2.1 Eli Lilly Diabetes Shipments, Price, Revenue and Gross profit 2013-2016
  3.2.2 Eli Lilly Diabetes Business Distribution by Region
  3.2.3 Interview Record
  3.2.4 Eli Lilly Diabetes Business Overview
  3.2.5 Eli Lilly Diabetes Product Specification
3.3 Sumitomo Dainippon Pharma Diabetes Business Introduction
  3.3.1 Sumitomo Dainippon Pharma Diabetes Shipments, Price, Revenue and Gross profit 2013-2016
  3.3.2 Sumitomo Dainippon Pharma Diabetes Business Distribution by Region
  3.3.3 Interview Record
  3.3.4 Sumitomo Dainippon Pharma Diabetes Business Overview
  3.3.5 Sumitomo Dainippon Pharma Diabetes Product Specification
3.4 Intarcia Therapeutics Diabetes Business Introduction
3.5 Servier Diabetes Business Introduction
3.6 Jiangsu Hansoh Pharmaceutical Diabetes Business Introduction

SECTION 4 INDIA DIABETES MARKET SEGMENTATION (PRODUCT TYPE LEVEL)

4.1 India Diabetes Market Segmentation (Product Type Level) Market Size 2013-2016
4.2 Different Diabetes Product Type Price 2013-2016
4.3 India Diabetes Market Segmentation (Product Type Level) Analysis

SECTION 5 INDIA DIABETES MARKET SEGMENTATION (INDUSTRY LEVEL)

5.1 India Diabetes Market Segmentation (Industry Level) Market Size 2013-2016
5.2 Different Industry Price 2013-2016
5.3 India Diabetes Market Segmentation (Industry Level) Analysis

SECTION 6 INDIA DIABETES MARKET SEGMENTATION (CHANNEL LEVEL)

6.1 India Diabetes Market Segmentation (Channel Level) Sales Volume and Share 2013-2016
6.2 India Diabetes Market Segmentation (Channel Level) Analysis

SECTION 7 DIABETES MARKET FORECAST 2017-2021

7.1 Diabetes Segmentation Market Forecast (Product Type Level)
7.2 Diabetes Segmentation Market Forecast (Industry Level)
7.3 Diabetes Segmentation Market Forecast (Channel Level)

SECTION 8 DIABETES SEGMENTATION PRODUCT TYPE

8.1 Alpha-glucosidase Inhibitors Product Introduction
8.2 Amylin Agonists Product Introduction
8.3 Biguanides Product Introduction
8.4 Dipeptidyl Peptidase-4 (DPP4) Inhibitors Product Introduction
8.5 Glinides / Meglitinides Product Introduction

SECTION 9 DIABETES SEGMENTATION INDUSTRY

9.1 Hospital Pharmacy Clients
9.2 Retail Pharmacies Clients
9.3 Online Pharmacy Clients

SECTION 10 DIABETES COST OF PRODUCTION ANALYSIS

10.1 Raw Material Cost Analysis
10.2 Technology Cost Analysis
10.3 Labor Cost Analysis
10.4 Cost Overview

SECTION 11 CONCLUSION

CHART AND FIGURE

Figure Diabetes Product Picture from GSK
Chart 2013-2016 India Manufacturer Diabetes Shipments (Units)
Chart 2013-2016 India Manufacturer Diabetes Shipments Share
Chart 2013-2016 India Manufacturer Diabetes Business Revenue (Million USD)
Chart 2013-2016 India Manufacturer Diabetes Business Revenue Share
Chart GSK Diabetes Shipments, Price, Revenue and Gross profit 2013-2016
Chart GSK Diabetes Business Distribution
Chart GSK Interview Record (Partly)
Figure GSK Diabetes Product Picture
Chart GSK Diabetes Business Profile
Table GSK Diabetes Product Specification
Chart Eli Lilly Diabetes Shipments, Price, Revenue and Gross profit 2013-2016
Chart Eli Lilly Diabetes Business Distribution
Chart Eli Lilly Interview Record (Partly)
Figure Eli Lilly Diabetes Product Picture
Chart Eli Lilly Diabetes Business Overview
Table Eli Lilly Diabetes Product Specification
Chart Sumitomo Dainippon Pharma Diabetes Shipments, Price, Revenue and Gross profit 2013-2016
Chart Sumitomo Dainippon Pharma Diabetes Business Distribution
Chart Sumitomo Dainippon Pharma Interview Record (Partly)
Figure Sumitomo Dainippon Pharma Diabetes Product Picture
Chart Sumitomo Dainippon Pharma Diabetes Business Overview
Table Sumitomo Dainippon Pharma Diabetes Product Specification
Chart Diabetes Market Segmentation (Product Type Level) Volume (Units) 2013-2016
Chart Diabetes Market Segmentation (Product Type Level) Market Size (Million $) 2013-2016
Chart Different Diabetes Product Type Price ($/Unit) 2013-2016
Chart Diabetes Market Segmentation (Industry Level) Market Size (Volume) 2013-2016
Chart Diabetes Market Segmentation (Industry Level) Market Size (Volume) 2013-2016
Chart Diabetes Market Segmentation (Industry Level) Market Size (Value) 2013-2016
Chart India Diabetes Market Segmentation (Channel Level) Sales Volume (Units) 2013-2016
Chart India Diabetes Market Segmentation (Channel Level) Share 2013-2016
Chart Diabetes Segmentation Market Forecast (Product Type Level) 2017-2021
Chart Diabetes Segmentation Market Forecast (Industry Level) 2017-2021
Chart Diabetes Segmentation Market Forecast (Channel Level) 2017-2021
Chart Alpha-glucosidase Inhibitors Product Figure
Chart Alpha-glucosidase Inhibitors Product Advantage and Disadvantage Comparison
Chart Amylin Agonists Product Figure
Chart Amylin Agonists Product Advantage and Disadvantage Comparison
Chart Biguanides Product Figure
Chart Biguanides Product Advantage and Disadvantage Comparison
Chart Dipeptidyl Peptidase-4 (DPP4) Inhibitors Product Figure
Chart Dipeptidyl Peptidase-4 (DPP4) Inhibitors Product Advantage and Disadvantage Comparison
Chart Glinides / Meglitinides Product Figure
Chart Glinides / Meglitinides Product Advantage and Disadvantage Comparison
Chart Hospital Pharmacy Clients
Chart Retail Pharmacies Clients
Chart Online Pharmacy Clients


More Publications